A Multi Center, Phase IIIb Study to Evaluate the Efficacy of Response Guided Therapy Using Quantitative HBsAg Measurement in Patient With HBeAg Positive Chronic Hepatitis B:
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Entecavir; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms S-RGT
- 01 Sep 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jul 2012 Planned End Date changed from 1 Nov 2015 to 1 Aug 2016 as reported by ClinicalTrials.gov.
- 24 Jul 2012 Planned initiation date changed from 1 Dec 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.